Precept posterior fixation system offers the most advanced technologies in guide design, rod insertion, set screw delivery, and multiple reduction capabilities. Elegant yet powerful reduction options, impressive compression/distraction systems, and efficient instrumentation result in a system designed to address simple to most complex pathologies.
When used as a pedicle screw fixation system, the NuVasive Precept Spinal System is intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of the posterior thoracic, lumbar, and sacral spine:
- Degenerative disc disease (as defined by back pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies)
- Degenerative spondylolisthesis with objective evidence of neurologic impairment
- Fracture
- Dislocation
- Scoliosis
- Kyphosis
- Spinal tumor and/or
- Failed previous fusion (pseudoarthrosis)
About MIS
The trend in spine surgery for many procedures has been moving toward minimally invasive approaches. These include spine surgery for lumbar fusion, deformity surgery, cervical surgery and sacroiliac joint fusion. The benefits of minimally invasive spine surgery (MIS) include decreased pain, less blood loss, shorter hospital stays and faster recovery. However, there is a difficult learning curve for surgeons when mastering MIS procedures. Increasing familiarity with MIS techniques creates more options for surgeons treating spine conditions with the potential to decrease surgical complications. The goal of this conference is to update neurological and orthopedic surgeons, as well as allied health professionals on the latest advances in MIS surgical techniques.
About Nuvasive
NuVasive, Inc. (NASDAQ: NUVA) based in San Diego, California, is a medical device company focused on the design, development, and marketing of products for the surgical treatment of spine disorders. NuVasive’s product portfolio is focused on applications in the over $4.2 billion U.S. spine fusion market. The Company’s current principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery, or MAS, as well as a growing offering of cervical and motion preservation products. NuVasive® is a medical device company focused on developing minimally disruptive surgical products and procedurally integrated solutions for the spine.
The Company is the third largest medical device company in the $8.2 billion global spine market. NuVasive’s principal product offering is based on its Maximum Access Surgery, or MAS® platform. The MAS platform combines several categories of solutions that collectively minimize soft tissue disruption during spine surgery with maximum visualization and safe, easy reproducibility for the surgeon: a proprietary software-driven nerve avoidance system and intra-operative monitoring support; MaXcess®, a unique split-blade retractor system; a wide variety of specialized implants; and several biologic products to aid in the spinal fusion process. MAS significantly reduces surgery time and returns patients to activities of daily living much faster than conventional approaches.
With over 90 products today spanning lumbar, thoracic and cervical applications, the Company will continue to expand and evolve its offering predicated on its R&D focus. http://www.nuvasive.com